|
Market Closed -
Xetra
09:05:32 02/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 359.10 EUR | -2.41% |
|
+0.01% | +28.11% |
| 03/10 | AbbVie joins US government pilot to test drug discount rebates | RE |
| 30/09 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| Market Cap | 22TCr 19TCr 18TCr 16TCr 31TCr 20,94700Cr 31TCr 2,18700Cr 85TCr 10,70800Cr 82TCr 80TCr 34,36700Cr | P/E 2026 * |
25.5x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 26TCr 23TCr 22TCr 20TCr 37TCr 24,93500Cr 37TCr 2,60300Cr 1,00900Cr 12,74700Cr 97TCr 95TCr 40,91000Cr | EV / Sales 2026 * |
6.66x | EV / Sales 2027 * | 6.29x |
| Free-Float |
99.77% | Yield 2026 * |
2.5% | Yield 2027 * | 2.64% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
Tradegate
| AMG | Real-time | |
|
Boerse Muenchen
| AMG | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
Börse Stuttgart
| AMG | Delayed | |
|
London S.E.
| 0R0T | Delayed | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote | |
|
CBOE
| 0R0T | Real-time |
Last Transcript: Amgen Inc.
| 1 day | -2.41% | ||
| 1 week | +0.01% | ||
| Current month | -3.77% | ||
| 1 month | -5.69% | ||
| 3 months | +9.87% | ||
| 6 months | +18.42% | ||
| Current year | +28.11% |
| 1 week | 357.5 |  | 376.75 |
| 1 month | 325.5 | | 376.75 |
| Current year | 271.8 | | 383.05 |
| 1 year | 247.65 | | 383.05 |
| 3 years | 230 | | 383.05 |
| 5 years | 174.58 | | 383.05 |
| 10 years | 120.65 | | 383.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
| Director of Finance/CFO | 62 | 13/05/2010 | |
Sean Bruich
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.41% | +0.01% | - | - | 22TCr | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,01900Cr | |
| -1.02% | -5.60% | +35.72% | +64.82% | 62TCr | |
| +1.11% | -0.58% | +12.36% | +78.27% | 46TCr | |
| +0.34% | -3.01% | +61.79% | +41.79% | 36TCr | |
| -0.95% | -4.05% | +20.54% | +40.33% | 33TCr | |
| -1.46% | -2.89% | +10.57% | +26.54% | 27TCr | |
| -1.35% | -5.43% | -6.17% | +8.82% | 24TCr | |
| -1.04% | -2.79% | +35.30% | +54.42% | 22TCr | |
| -1.87% | -4.10% | +28.44% | +97.54% | 18TCr | |
| Average | -0.93% | -3.39% | +26.07% | +58.90% | 41.08TCr | |
| Weighted average by Cap. | -0.70% | -3.33% | +29.07% | +71.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.89TCr 3.46TCr 3.23TCr 2.94TCr 5.55TCr 3,74300Cr 5.6TCr 39TCr 15TCr 1,91400Cr 15TCr 14TCr 6,14100Cr | 4.03TCr 3.58TCr 3.34TCr 3.05TCr 5.75TCr 3,87500Cr 5.8TCr 40TCr 16TCr 1,98100Cr 15TCr 15TCr 6,35800Cr |
| Net income | 858.05Cr 762.38Cr 711.56Cr 648.56Cr 1.22TCr 82TCr 1.23TCr 8.61TCr 3.34TCr 42TCr 3.22TCr 3.15TCr 1,35300Cr | 939.28Cr 834.55Cr 778.92Cr 709.96Cr 1.34TCr 90TCr 1.35TCr 9.43TCr 3.65TCr 46TCr 3.53TCr 3.45TCr 1,48100Cr |
| Net Debt | 4.15TCr 3.69TCr 3.44TCr 3.14TCr 5.91TCr 3,98800Cr 5.97TCr 42TCr 16TCr 2,03900Cr 16TCr 15TCr 6,54300Cr | 3.58TCr 3.18TCr 2.97TCr 2.71TCr 5.11TCr 3,44300Cr 5.15TCr 36TCr 14TCr 1,76000Cr 13TCr 13TCr 5,64900Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | €359.10 | -2.41% | 233 |
| 01/26/01 | €367.95 | -1.39% | 522 |
| 30/26/30 | €373.15 | +1.44% | 355 |
| 29/26/29 | €367.85 | +0.73% | 393 |
| 28/26/28 | €365.20 | +1.71% | 704 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
- AMG Stock
Select your edition
All financial news and data tailored to specific country editions
